Investigating PXR (NR1I2) genetic polymorphisms as possible determinants of the magnitude of the clindamycin–rifampicin pharmacokinetic interaction
- DOI
- 10.1007/s00228-026-04166-9
- Published
- 2026-08-15
- Container
- European Journal of Clinical Pharmacology
- Publisher
- Springer Science and Business Media LLC
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1007/s00228-026-04166-9,
title = {Investigating PXR (NR1I2) genetic polymorphisms as possible determinants of the magnitude of the clindamycin–rifampicin pharmacokinetic interaction},
author = {Valérie Zeller and Estelle Lu and Léo Mimram and Kamilia Brinis and Younes Kerroumi and Armelle Arnoux and Marie-Anne Loriot and Céline Narjoz and Vincent Jullien},
year = {2026},
journal = {European Journal of Clinical Pharmacology},
doi = {10.1007/s00228-026-04166-9},
url = {https://doi.org/10.1007/s00228-026-04166-9}
}RIS
TY - JOUR TI - Investigating PXR (NR1I2) genetic polymorphisms as possible determinants of the magnitude of the clindamycin–rifampicin pharmacokinetic interaction AU - Valérie Zeller AU - Estelle Lu AU - Léo Mimram AU - Kamilia Brinis AU - Younes Kerroumi AU - Armelle Arnoux AU - Marie-Anne Loriot AU - Céline Narjoz AU - Vincent Jullien PY - 2026 JO - European Journal of Clinical Pharmacology DO - 10.1007/s00228-026-04166-9 UR - https://doi.org/10.1007/s00228-026-04166-9 ER -
APA
Zeller, V., Lu, E., Mimram, L., Brinis, K., Kerroumi, Y., Arnoux, A., Loriot, M., Narjoz, C., & Jullien, V. (2026). Investigating PXR (NR1I2) genetic polymorphisms as possible determinants of the magnitude of the clindamycin–rifampicin pharmacokinetic interaction. European Journal of Clinical Pharmacology. https://doi.org/10.1007/s00228-026-04166-9
Source records
- crossref · retrieved 2026-09-26T13:26:34.846Z